4C Medical
Developer of a novel minimally invasive system designed for the treatment of mitral regurgitation. The company's system directly addresses the complication without replacing the native mitral valve t...
Valuation
$0
Share Price
N/A
Total Raised
$165.1M
Last Round
N/A